Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy-Reference-Cited by-同舟云学术

Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy

Published:2021-06-01 Issue:6 Volume:78 Page:736
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Patel Arpan¹,Sul James¹,Gordon Marc L.²³,Steinklein Jared⁴,Sanguinetti Shayna¹,Pramanik Bidyut⁴,Purohit Dushyant⁵⁶,Haroutunian Vahram⁶⁷⁸,Williamson Alex⁹,Koralnik Igor¹⁰,Harel Asaff¹¹

Affiliation:

1. Department of Neurology, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York

2. Department of Neurology, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Feinstein Institutes for Medical Research, Manhasset, New York

3. Department of Psychiatry, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Feinstein Institutes for Medical Research, Manhasset, New York

4. Division of Neuroradiology, Department of Radiology, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York

5. Department of Pathology, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York

6. Department of Psychiatry, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York

7. MIRECC, JJ Peters VA Medical Center, Bronx, New York

8. Department of Neuroscience, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York

9. Department of Pathology & Laboratory Medicine, LIJ Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York

10. Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois

11. Division of Neuro-Immunology, Department of Neurology, Lenox Hill Hospital, North Shore University Hospital, Zucker School of Medicine at Hofstra/Northwell, New York, New York

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2777642/jamaneurology_patel_2021_br_210001_1622672687.24783.pdf

Reference16 articles.

1. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.;Gheuens;J Neurol Neurosurg Psychiatry,2010

2. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.;Pavlovic;Ther Adv Neurol Disord,2015

3. Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.;Berger;J Neurovirol,2018

4. Pembrolizumab treatment for progressive multifocal leukoencephalopathy.;Cortese;N Engl J Med,2019

5. Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.;Prosperini;J Neurovirol,2017

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy;Frontiers in Immunology;2024-07-17

2. Progressive multifocal leukoencephalopathy in association with siponimod treatment for secondary progressive multiple sclerosis: a case report;Journal of Neurology;2024-07-03

3. Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy;Drug Design, Development and Therapy;2024-07

4. Ocrelizumab-induced organizing pneumonia in multiple sclerosis: case report and literature review;Archive of Clinical Cases;2024-06-30

5. Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study;Journal of Central Nervous System Disease;2024-05-05